Water-soluble phenol TS-13 combats acute but not chronic inflammation
- 3 June 2014
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 63 (9) , 729-740
Abstract
This study was conducted to evaluate the effect of the synthetic water-soluble phenolic antioxidant TS-13 (sodium 3-(4'-methoxyphenyl)propyl thiosulfonate), an inducer of the redox-dependent Keap1/Nrf2/ARE signaling system, in experimental models of acute and chronic inflammation. Acute local inflammation was induced by intraplantar carrageenan injection into rat hind paws, and acute systemic inflammation was modeled by intravenous zymosan injection (in rats) or LPS-induced endotoxic shock (in mice). Chronic inflammation was investigated in rat models of air pouch and collagen-induced arthritis. The effects of TS-13 treatment were estimated by changes in the intensity of inflammation (paw edema, liver infiltration, animal survival, exudation, and clinical score of arthritis) and by the effects on reactive oxygen species (ROS) generation by leukocytes from peripheral blood and inflammatory exudates. We found the significant increase in expression of mRNA, content of protein and activity of a well-characterized Nrf2 target enzyme glutathione S-transferase P1, as well as nuclear extract protein binding to the ARE consensus sequence in liver of mice fed with diet containing TS-13. TS-13 markedly attenuated carrageenan-induced paw edema, reduced blood granulocyte number and volume density of liver infiltrates in the systemic zymosan-induced inflammation model, and increased mice survival after lipopolysaccharide-induced septic shock. However, TS-13 administration did not influence cell and protein exudation into air pouches and suppressed clinical manifestation of collagen-induced polyarthritis only at early stages. Nevertheless, TS-13 inhibited the generation of ROS by leukocytes in all inflammation models. The data suggest that the anti-inflammatory effects of Keap1/Nrf2/ARE system are more prominent against acute innate-mediated inflammation than chronic immune inflammation. This narrows the potential therapeutic efficacy of ARE inducers in inflammation treatment.Keywords
This publication has 35 references indexed in Scilit:
- Th2 Skewing by Activation of Nrf2 in CD4+ T CellsThe Journal of Immunology, 2012
- Enhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Basic Principles and Emerging Concepts in the Redox Control of Transcription FactorsAntioxidants & Redox Signaling, 2011
- Current Concepts of Hyperinflammation in Chronic Granulomatous DiseaseJournal of Immunology Research, 2011
- Rodent Preclinical Models for Developing Novel Antiarthritic Molecules: Comparative Biology and Preferred Methods for Evaluating EfficacyBioMed Research International, 2010
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient MiceThe Journal of Immunology, 2010
- Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysisNucleic Acids Research, 2010
- Cigarette Smoking Blocks the Protective Expression of Nrf2/ARE Pathway in Peripheral Mononuclear Cells of Young Heavy Smokers Favouring InflammationPLOS ONE, 2009
- Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsisJournal of Clinical Investigation, 2006